Hartman Michael J, Caccamese John F, Bergman Stewart A
University of Maryland Medical Center, R. Adams Cowley Shock Trauma Unit, Baltimore College of Dental Surgery, Baltimore, MD 21201, USA.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 May;103(5):626-9. doi: 10.1016/j.tripleo.2006.08.030. Epub 2006 Dec 13.
Bernard-Soulier Syndrome (BSS) is a disease characterized by prolonged bleeding time, thrombocytopenia, and extremely large platelets and has a prevalence of less than 1 in 1,000,000. Patients with disorders of coagulation and bleeding can be among the most difficult surgical patients to manage. Perioperative hemorrhage can contribute to life-threatening complications in even the most routine surgical procedures. Because of the rarity of BSS, there are no well-defined protocols for the management of perioperative bleeding associated with this condition. Treatment with preoperative and intraoperative systemic aminocaproic acid, HLA-matched platelets, and topical gelfoam and thrombin resulted in sustained hemostasis and a durable healing response. For those rare few afflicted with this disease, we present a combined systemic and topical approach that may be helpful in the control and prevention of perioperative hemorrhage in this and other similar platelet disorders.
伯纳德-索利尔综合征(BSS)是一种以出血时间延长、血小板减少和血小板极大为特征的疾病,其患病率低于百万分之一。凝血和出血障碍患者可能是最难管理的外科手术患者之一。即使在最常规的外科手术中,围手术期出血也可能导致危及生命的并发症。由于BSS罕见,尚无针对与该病症相关的围手术期出血管理的明确方案。术前和术中使用全身氨甲环酸、人类白细胞抗原匹配的血小板以及局部使用明胶海绵和凝血酶进行治疗,实现了持续止血和持久的愈合反应。对于极少数患有这种疾病的患者,我们提出了一种联合全身和局部的方法,这可能有助于控制和预防该疾病及其他类似血小板疾病的围手术期出血。